AGO2 and central nervous system cancer: The glioma cells were transfection of miR-542-5p inhibitor and control for 48 h, and treated with or without pristimerin (1 μM) for 24 h, then qRT-PCR was performed to determine the expression of AGO2 and PTPN1.